369 related articles for article (PubMed ID: 7942045)
1. Xanthine dehydrogenase and purine metabolism in man. With special reference to exercise.
Hellsten Y
Acta Physiol Scand Suppl; 1994; 621():1-73. PubMed ID: 7942045
[No Abstract] [Full Text] [Related]
2. [Is xanthine oxidase a universal source of superoxide radicals in ischemic and reperfusion lesions?].
Rashba IuE; Nagler LG; Vartanian LS; Oktiabr'skaia LA; Bilenko MV
Biull Eksp Biol Med; 1990 Jun; 109(6):548-50. PubMed ID: 2168771
[TBL] [Abstract][Full Text] [Related]
3. Relationship of oxypurine release to contractile failure in dinitrophenol-treated rat skeletal muscle.
Majumdar R; Cwik VA; Solonynko G; Brooke MH
Acta Physiol Scand; 1993 Nov; 149(3):249-55. PubMed ID: 8310832
[TBL] [Abstract][Full Text] [Related]
4. [Xanthine dehydrogenase (xanthine oxidase)].
Ichida K; Yamaguchi Y; Matsumura T
Nihon Rinsho; 2003 Jan; 61 Suppl 1():98-102. PubMed ID: 12629699
[No Abstract] [Full Text] [Related]
5. Uric acid predicts clinical outcomes in heart failure: insights regarding the role of xanthine oxidase and uric acid in disease pathophysiology.
Hare JM; Johnson RJ
Circulation; 2003 Apr; 107(15):1951-3. PubMed ID: 12707249
[No Abstract] [Full Text] [Related]
6. Renal purine efflux and xanthine oxidase activity during experimental nephrosis in rats: difference between puromycin aminonucleoside and adriamycin nephrosis.
Ginevri F; Gusmano R; Oleggini R; Acerbo S; Bertelli R; Perfumo F; Cercignani G; Allegrini S; D'Allegri F; Ghiggeri G
Clin Sci (Lond); 1990 Mar; 78(3):283-93. PubMed ID: 2156648
[TBL] [Abstract][Full Text] [Related]
7. Xanthine oxidoreductase activity in perfused hearts of various species, including humans.
de Jong JW; van der Meer P; Nieukoop AS; Huizer T; Stroeve RJ; Bos E
Circ Res; 1990 Sep; 67(3):770-3. PubMed ID: 2397579
[TBL] [Abstract][Full Text] [Related]
8. Study of purine metabolism in a xanthinuric female.
Bradford MJ; Krakoff IH; Leeper R; Balis ME
J Clin Invest; 1968 Jun; 47(6):1325-32. PubMed ID: 5653212
[TBL] [Abstract][Full Text] [Related]
9. NADH oxidase activity of rat liver xanthine dehydrogenase and xanthine oxidase-contribution for damage mechanisms.
Maia L; Vala A; Mira L
Free Radic Res; 2005 Sep; 39(9):979-86. PubMed ID: 16087479
[TBL] [Abstract][Full Text] [Related]
10. In vivo and in vitro 1-methylxanthine metabolism in the rat. Evidence that the dehydrogenase form of xanthine oxidase predominates in intact perfused liver.
Reinke LA; Nakamura M; Logan L; Christensen HD; Carney JM
Drug Metab Dispos; 1987; 15(3):295-9. PubMed ID: 2886302
[TBL] [Abstract][Full Text] [Related]
11. [Mechanism of exercise-induced hyperuricemia].
Hadano S; Ogasawara M; Ito A
Nihon Seirigaku Zasshi; 1987; 49(5):151-9. PubMed ID: 3681743
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of 3,5,2',4'-Tetrahydroxychalcone on Production of Uric Acid in Hypoxanthine-Induced Hyperuricemic Mice.
Niu Y; Zhou Y; Lin H; Gao LH; Xiong W; Zhu H; Zou CG; Li L
Biol Pharm Bull; 2018 Jan; 41(1):99-105. PubMed ID: 29093325
[TBL] [Abstract][Full Text] [Related]
13. A novel cancer therapy based on oxygen radicals.
Yoshikawa T; Kokura S; Tainaka K; Naito Y; Kondo M
Cancer Res; 1995 Apr; 55(8):1617-20. PubMed ID: 7712462
[TBL] [Abstract][Full Text] [Related]
14. Plasma concentrations and urinary excretion of purine bases (uric acid, hypoxanthine, and xanthine) and oxypurinol after rigorous exercise.
Kaya M; Moriwaki Y; Ka T; Inokuchi T; Yamamoto A; Takahashi S; Tsutsumi Z; Tsuzita J; Oku Y; Yamamoto T
Metabolism; 2006 Jan; 55(1):103-7. PubMed ID: 16324927
[TBL] [Abstract][Full Text] [Related]
15. Exchange of hypoxanthine in muscle during intense exercise in man.
Bangsbo J; Sjödin B; Hellsten-Westing Y
Acta Physiol Scand; 1992 Dec; 146(4):549-50. PubMed ID: 1492576
[No Abstract] [Full Text] [Related]
16. Xanthine oxidase activity: simultaneous HPLC evaluation of the "D" and "O" forms.
Cighetti G; Del Puppo M; Andreetta F; Kienle MG
Biochem Int; 1989 Jun; 18(6):1211-20. PubMed ID: 2751684
[TBL] [Abstract][Full Text] [Related]
17. New insights into purine metabolism in metabolic diseases: role of xanthine oxidoreductase activity.
Furuhashi M
Am J Physiol Endocrinol Metab; 2020 Nov; 319(5):E827-E834. PubMed ID: 32893671
[TBL] [Abstract][Full Text] [Related]
18. Purine and oxypurine production in mitochondria of ischemic and reperfused myocardium.
van Jaarsveld H; Barnard HC; Barnard SP; Maartens JJ; Potgieter GM
Enzyme; 1989; 42(3):136-44. PubMed ID: 2612453
[TBL] [Abstract][Full Text] [Related]
19. Myocardial xanthine oxidase/dehydrogenase.
Schoutsen B; De Jong JW; Harmsen E; De Tombe PP; Achterberg PW
Biochim Biophys Acta; 1983 Jul; 762(4):519-24. PubMed ID: 6575831
[TBL] [Abstract][Full Text] [Related]
20. [Mechanism of action and role of xanthine oxidoreductases (author's transl)].
Jezewska MM
Postepy Biochem; 1974; 20(3):259-79. PubMed ID: 4849147
[No Abstract] [Full Text] [Related]
[Next] [New Search]
